Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 238,263,035 papers from all fields of science
Search
Sign In
Create Free Account
efatutazone
Known as:
2,4-Thiazolidinedione, 5-((4-((6-(4-Amino-3,5-Dimethylphenoxy)-1-Methyl-1H-Benzimidazol-2-yl)Methoxy)Phenyl)Methyl)-
, Inolitazone
, Rac-5-((4-((6-(4-Amino-3,5-Dimethylphenoxy)-1-Methyl-1H-Benzimidazol-2-yl)Methoxy)Phenyl)Methyl)-1,3-Thiazolidine-2,4-Dione
An orally bioavailable thiazolidinedione and an agonist of peroxisome proliferator-activated receptor gamma (PPAR-gamma) with potential…
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
5 relations
Broader (2)
Antineoplastic Agents
Thiazolidinediones
Narrower (2)
CS 7017
RS 5444
NCIt Antineoplastic Agent Terminology
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2014
2014
Abstract CT311: A randomized, open-label phase 2 study of efatutazone and erlotinib as second- or third-line therapy for non-small cell lung cancer (NSCLC)
A. Oton
,
B. Cho
,
+10 authors
J. Pawel
2014
Corpus ID: 71935229
Proceedings: AACR Annual Meeting 2014; April 5-9, 2014; San Diego, CA Introduction: Efatutazone is a potent, highly selective…
Expand
2012
2012
Abstract 4606: Randomized phase 2 study of efatutazone in combination with carboplatin and paclitaxel as first-line therapy for metastatic non-small cell lung cancer (NSCLC)
A. Shaw
,
D. Ghizdavescu
,
+7 authors
R. Roemeling
2012
Corpus ID: 72472149
Proceedings: AACR 103rd Annual Meeting 2012‐‐ Mar 31‐Apr 4, 2012; Chicago, IL Background: Efatutazone, a highly-selective…
Expand